Accent Microcell IPO Date, Price, GMP, Review and Best 3 IPOs to Invest

Hello my fellow finance enthusiasts, there is a huge investment opportunity opening up in the near future. Yes, you heard absolutely right. The Accent Microcell IPO is going to open soon. So I will give you complete information about Accent Microcell IPO here on IPO India.

On this article I will inform you about Accent Microcell IPO Date, Price, GMP, Review and Best 3 IPOs to Invest. So without wasting any more time let’s start.

About Accent Microcell Ltd.

Established on April 10, 2012, Accent Microcell Limited manufactures high quality cellulose-based excipients primarily for the pharmaceutical, nutraceutical, food, cosmetic and other industries. The company has excelled in manufacturing high-quality cellulose-based excipients, meeting international quality standards. The company operates two state-of-the-art manufacturing facilities at Pirana Road in Ahmedabad and Dahej SEZ in Bharuch. These facilities have enabled it to develop a strong global sales model, serving customers across India and in over 45 countries worldwide, including USA, Canada, Germany, UK, Japan, China, Australia, Korea, Netherlands, Turkey, Vietnam, Italy. , Indonesia, Poland, Egypt, France, Thailand, New Zealand, Brazil, Russia, Mexico, Chile, Zimbabwe, Denmark and Greece.

The company specializes in the production of microcrystalline cellulose (“MCC”), an odorless, fine white powder, a pure form of cellulose obtained from the purification of highly purified wood pulp. It is widely used as a texturizer, anticaking agent, binder, lubricant, bulking agent and diluent and finds a wide range of applications in the pharmaceutical, nutraceutical, food, cosmetic and other industries. The company produces 22 grades of MCC, with particle sizes ranging from 20 microns to 180 microns. The main grade of MCC manufactured and marketed by the company is known as “Excel”. In addition to “Axel”, the company also sells products under the names “Acrocell”, “Macell”, and “Wincell”.

Accent Microcell IPO GMP

About Accent Microcell IPO

Here is some information about Accent Microcell IPO which will help you in making a decision to invest in Accent Microcell IPO. It appears to be a book-built offer with a total value of Rs. 78.40 crores, including 56 lakh shares offer for sale in full.

Summary of the key details

• Issue Size: Rs. 78.40 crores
• Offer for Sale: 56 Lakh shares
• Subscription Period: December 08, 2023, to December 12, 2023.
• Allotment Date: Expected on Wednesday, December 13, 2023.
• Listing Date: Tentatively scheduled for Friday, December 15, 2023, on NSE SME

Price Range of Accent Microcell IPO

• ₹133 to ₹140 per share

Lot Size of Accent Microcell IPO

• Minimum Lot: 1000 Shares.
• Minimum Investment for Retail Investors: ₹140,000

Minimum Lot Size Investments for Accent Microcell IPO

• HNI: 2 lots (2,000 shares), amounting to ₹280,000.

This information provides potential investors with the details they need to participate in the Accent Microcell IPO. It is important to note that investing in IPOs carries risks, and individuals should do their own research or consult financial professionals before making investment decisions.

To Open a trading and demat account in Zerodha

Accent Microcell IPO

To know more about IPOs.

Valuations of Accent Microcell IPO

Accent Microcell Limited Financial Information

Promoter(s)

Company Promotor(s):-

1. Mr. Vasant Vadilal Patel
2. Mr. Ghanshyam Arjanbhai Patel
3. Mr. Nitin Jasvantbhai Patel
4. Mr. Vinodbhai Manibhai Patel

If you are new to the investment section and want to know how to invest in IPOs, you can read our article “How to Invest in IPOs?“.

Key Performance Indicator

Issue Objective(s)

• To set up a plant at Navagam Kheda for manufacturing Croscarmellose Sodium (CCS), Sodium Starch Glycolate and Carboxymethylcellulose (CMC)
• General Corporate Expenses

Accent Microcell IPO Registrar

Accent Microcell IPO Review

As an investor evaluating the Accent Microcell IPO, there are several aspects that catch my attention. Established in 2012, the company has positioned itself as a major player in the production of high-quality cellulose-based excipients for various industries. With a global sales model spanning 45 countries, including notable markets such as the USA, Germany and Japan, Accent Microcell demonstrates a strong international presence.

The focus on the production of microcrystalline cellulose (MCC), a versatile material widely used in pharmaceuticals, nutraceuticals, food, cosmetics and other industries, aligns well with the growing demand for such ingredients globally. The company’s diversified product portfolio, including notable grades such as “Excel”, demonstrates its commitment to cater to a wide range of customer needs.

Checking the details of the IPO, the issue size is Rs. 78.40 crore, with 56 lakh shares offered for sale, indicating a mid-sized offer. The subscription period from December 8 to December 12, 2023 and listing tentatively scheduled for December 15, 2023 on NSE SME provides a clear timeline for potential investors.

Price Range Rs. 133 to Rs. 140 per share, with a minimum lot size of 1000 shares, can attract a diverse investor profile. Earnings per share (EPS) Rs. 10.06, price-to-earnings (P/E) ratio of 13.92 and strong return on net worth (RoNW) of 29.44% indicate positive financial performance.

The company’s expansion plans, outlined in the issue objectives, demonstrate strategic forward-thinking to set up plants to manufacture additional products such as croscarmellose sodium and sodium starch glycolate.

Conclusion

In conclusion, the Accent Microcell IPO looks interesting for investors seeking exposure to a company operating in a niche market with a global footprint. However, it is important for potential investors to conduct their due diligence in view of market conditions and the inherent risks associated with investing in IPOs. As with any investment decision, it is advisable to consult with financial professionals and carefully evaluate your investment objectives before participating in an IPO.

While the Accent Microcell IPO presents an exciting opportunity, wise and informed decision-making should be the foundation of any investment strategy. Happy investing!

Accent Microcell IPO FAQs